Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae168 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Nicolas Fourre und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Streptococcal Infections, Bacteremia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Streptococcal bacteremia is associated with high mortality. Thia study aims to identify predictors of mortality among patients with streptococcal bacteremia.
Methods
This retrospective study was conducted at the Lausanne University Hospital, Switzerland, and included episodes of streptococcal bacteremia among adult patients from 2015 to 2023.
Results
During the study period, 861 episodes of streptococcal bacteremia were included. The majority of episodes were categorized in the Mitis group (348 episodes; 40%), followed by the Pyogenic group (215; 25%). Endocarditis was the most common source of bacteremia (164; 19%). The overall 14-day mortality rate was 8% (65 episodes). The results from the Cox multivariable regression model showed that a Charlson comorbidity index >4 (P .001; hazard ratio [HR], 2.87; confidence interval [CI]: 1.58–5.22), Streptococcus pyogenes (P = .011; HR, 2.54;CI: 1.24–5.21), sepsis (P < .001; HR, 7.48; CI: 3.86–14.47), lower respiratory tract infection (P = .002; HR, 2.62; CI: 1.42–4.81), and absence of source control interventions within 48 hours despite being warranted (P = .002; HR, 2.62; CI: 1.43–4.80) were associated with 14-day mortality. Conversely, interventions performed within 48 hours of bacteremia onset, such as infectious diseases consultation (P < .001; HR, 0.29; CI: .17–.48) and appropriate antimicrobial treatment (P < .001; HR, .28; CI: .14–.57), were associated with improved outcome.
Conclusions
Our findings underscore the pivotal role of infectious diseases consultation in guiding antimicrobial treatment and recommending source control interventions for patients with streptococcal bacteremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Service, Lausanne University Hospital, Lausanne, Switzerland.
- Infection Prevention and Control Unit, Lausanne University Hospital, Lausanne, Switzerland.
- Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
- Infectious Diseases Service, Cantonal Hospital of Sion and Institut Central des Hôpitaux (ICH), Sion, Switzerland.
ORCID-Profile: Matthaios Papadimitriou-Olivgeris
Zitieren
APA
Fourre, N., Zimmermann, V., Senn, L., Aruanno, M., Guery, B., & Papadimitriou-Olivgeris, M. (2024). Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae168
Vancouver
Fourre N, Zimmermann V, Senn L, Aruanno M, Guery B, Papadimitriou-Olivgeris M. Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae168
BibTeX
@article{Fourre2024,
author = {Fourre, Nicolas and Zimmermann, Virgile and Senn, Laurence and Aruanno, Marion and Guery, Benoit and Papadimitriou-Olivgeris, Matthaios},
title = {Predictors of Mortality of Streptococcal Bacteremia and the Role of Infectious Diseases Consultation: A Retrospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae168}
}
EUVIMED